>>13683925
o7
https://allthatsinteresting.com/bloody-mary#:~:text=The%20origin%20of%20the%20Bloody,at%20the%20Palace%20of%20Placentia.
>>13683925
o7
https://allthatsinteresting.com/bloody-mary#:~:text=The%20origin%20of%20the%20Bloody,at%20the%20Palace%20of%20Placentia.
>>13683943
>>13683959
Payseur slide caught.
2 Questions asked, ignored the one about PAIN. Date? 19
Q's Trip Slip? Now comes the Pain. 19th.
PAYTRIOT.
ince 1969, USAMRIID has served as the Department of Defense's (DoD) lead laboratory for medical biological defense research. While our core mission is to protect the warfighter from biological threats, we also investigate disease outbreaks and threats to public health. Research conducted at USAMRIID leads to medical solutions—therapeutics, vaccines, diagnostics, and information—that benefit both military personnel and civilians. USAMRIID is a subordinate laboratory of the U.S. Army Medical Research and Development Command.
https://www.usamriid.army.mil/
Defense Advanced Research Projects Agency (DARPA)
http://www.darpa.mil/ External Link, Opens in New Window
Home page of DARPA describes basic and applied research and development projects being performed for Department of Defense.
Department of Health and Human Services
http://www.hhs.gov/ External Link, Opens in New Window
United States Government's principal agency for protecting the health of all Americans and providing essential human services. This site also includes a Search Engine.
https://www.usamriid.army.mil/govlinks.htm
Moderna Wins Initial $20M Grant from Gate Foundation
https://www.genengnews.com/topics/omics/moderna-wins-initial-20m-grant-from-gates-foundation/
Then, in October, the government's DefenseÂ
Advanced Research Projects Agency (DARPA) awarded Moderna $25 million to develop mRNA to combat infectious diseases an biological threats
https://www.alumni.hbs.edu/stories/Pages/story-bulletin.aspx?num=3170
“We created a center here in Texas to develop vaccines that the big pharma companies are not in a position to make because there's not a financial model for the shareholders,” Dr. Hotez said during a recent episode of the “AMA COVID-19 Update” about his 10 years of work with coronaviruses. He is the dean of the National School of Tropical Medicine, and professor of pediatrics and molecular virology and microbiology at Baylor College of Medicine in Houston.
“About 10 years ago, we got connected to a virology group at the New York Blood Center led by Shibo Jiang, MD, PhD, and Lanying Du, PhD, who had a pretty good idea for coronavirus vaccines,” said Dr. Hotez who is also co-director of the Center for Vaccine Development with Maria Elena Bottazzi, PhD at the Texas Children’s Hospital.“At the time, interest in coronavirus vaccines was not high. They were sort of orphaned, so we adopted it just like we adopted Chagas disease vaccines and leishmaniasis vaccines.”
“We formed a consortium, together with the Galveston National Laboratory (Kent Tseng, PhD) and Walter Reed Army Institute of Research,” he said.
https://www.ama-assn.org/delivering-care/public-health/how-decade-coronavirus-research-paved-way-covid-19-vaccines